SynthesisJournal for immunotherapy of cancer2018

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

Vivek Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.